Locoregional treatment for hepatocellular carcinoma: From clinical exploration to robust clinical data, changing standards of care

Editorial

Alejandro Forner et al. Hepatology. 2008 Jan.

. 2008 Jan;47(1):5-7.

doi: 10.1002/hep.22152.

No abstract available

Comment on

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?
Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, Rossi S. Livraghi T, et al. Hepatology. 2008 Jan;47(1):82-9. doi: 10.1002/hep.21933. Hepatology. 2008. PMID: 18008357
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.
Kulik LM, Carr BI, Mulcahy MF, Lewandowski RJ, Atassi B, Ryu RK, Sato KT, Benson A 3rd, Nemcek AA Jr, Gates VL, Abecassis M, Omary RA, Salem R. Kulik LM, et al. Hepatology. 2008 Jan;47(1):71-81. doi: 10.1002/hep.21980. Hepatology. 2008. PMID: 18027884 Clinical Trial.